LLY - Lilly Eli & Co - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - LLY (59478)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
56 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P4-0+0+2+1
S19+0+0+3-4

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-06-14
LLYLilly Endowment Inc10%S - Sale$86.31-107,698122,230,8040%-$9,295,414
2018-06-14
LLYSkovronsky DanielSVP, CSO,, Pres LRLP - Purchase$86.22+10,00055,199+22%+$862,200
2018-06-13
LLYLilly Endowment Inc10%S - Sale$86.27-11,104122,338,5020%-$957,953
2018-06-11
LLYLilly Endowment Inc10%S - Sale$86.38-51,198122,349,6060%-$4,422,637
2018-06-04
LLYLilly Endowment Inc10%S - Sale$85.12-135,478122,400,8040%-$11,532,565
2018-06-01
LLYLilly Endowment Inc10%S - Sale$85.31-39,522122,536,2820%-$3,371,661
2018-05-31
LLYConterno Enrique ASVP, Pres, LillyDiab, LillyUSAS - Sale$85.00-25,000129,618-16%-$2,125,000
A
2018-05-29
LLYShaw ChristiSVP, Pres, Lilly Bio-MedsS - Sale$82.10-8,4260-100%-$691,775
2018-05-30
LLYLilly Endowment Inc10%S - Sale$83.85-180,000122,575,8040%-$15,092,640
2018-05-29
LLYShaw ChristiSVP, Pres, Lilly Bio-MedsS - Sale$82.10-8,4260-100%-$691,775
2018-05-11
LLYLilly Endowment Inc10%S - Sale$81.97-140,000122,755,8040%-$11,475,940
D
2018-05-03
LLYSimmons Jeffrey NSVP, Pres Elanco Animal HealthS - Sale+OE$78.50-9,027136,539-6%-$708,620
2018-04-25
LLYLilly Endowment Inc10%S - Sale$80.85-180,000122,895,8040%-$14,553,614
M
2018-04-13
LLYMahony SusanSVP, Pres, Lilly OncologyS - Sale$80.09-22,54446,612-33%-$1,805,633
2018-03-16
LLYSmiley Joshua LSVP, CFOS - Sale$79.20-3,00021,892-12%-$237,600
2018-03-01
LLYZakrowski Donald AChief Accounting OfficerS - Sale$76.50-8605,767-13%-$65,790
2018-02-21
LLYZakrowski Donald AChief Accounting OfficerS - Sale$77.55-8766,602-12%-$67,934
2018-02-05
LLYZakrowski Donald AChief Accounting OfficerS - Sale$81.09-9007,478-11%-$72,981
D
2018-02-05
LLYSimmons Jeffrey NSVP, Pres Elanco Animal HealthS - Sale+OE$81.12-9,625134,275-7%-$780,780
2017-12-13
LLYLilly Endowment Inc10%S - Sale$88.20-200,000123,075,8040%-$17,639,176
2017-12-11
LLYSimmons Jeffrey NSVP, Pres Elanco Animal HealthS - Sale$86.46-12,500119,206-9%-$1,080,750
2017-12-04
LLYZulueta Alfonso GSVP, Pres, Lilly Int'lS - Sale$86.00-3,53244,442-7%-$303,752
2017-12-04
LLYMahony SusanSVP, Pres, Lilly OncologyS - Sale$86.18-36,58555,974-40%-$3,152,895
2017-11-10
LLYZulueta Alfonso GSVP, Pres, Lilly Int'lS - Sale$83.67-2,00347,949-4%-$167,591
2017-10-04
LLYLilly Endowment Inc10%S - Sale$86.81-205,000123,275,8040%-$17,795,025
2017-09-29
LLYLilly Endowment Inc10%S - Sale$85.14-195,000123,480,8040%-$16,602,601
2017-09-15
LLYLilly Endowment Inc10%S - Sale$82.53-190,000123,675,8040%-$15,679,772
2017-08-31
LLYLilly Endowment Inc10%S - Sale$81.06-180,000123,865,8040%-$14,590,080
2017-07-31
LLYLilly Endowment Inc10%S - Sale$83.09-220,000124,045,8040%-$18,279,478
2017-06-22
LLYLilly Endowment Inc10%S - Sale$84.43-210,000124,265,8040%-$17,730,720
2017-06-20
LLYLilly Endowment Inc10%S - Sale$83.05-215,000124,475,8040%-$17,855,363
2017-06-12
LLYBarnes Melissa SChief Eth, Cmpl Ofcr, SVP, ERMS - Sale$80.78-1,90014,905-11%-$153,482
2017-06-09
LLYHarrington Michael JSVP, GCS - Sale$79.97-22,83362,484-27%-$1,825,955
2017-05-04
LLYConterno Enrique ASVP, Pres, LillyDiab, LillyUSAS - Sale$82.76-25,000119,172-17%-$2,069,000-2-2
2017-03-30
LLYLilly Endowment Inc10%S - Sale$84.67-210,000124,690,8040%-$17,781,540-1+1-3
2017-02-17
LLYLilly Endowment Inc10%S - Sale$80.27-230,000125,125,8040%-$18,462,7900+3+4
2017-02-06
LLYZulueta Alfonso GSVP,Pres, Emerging MarketsS - Sale$77.66-15,00049,870-23%-$1,164,900+1+2+10
DM
2017-02-02
LLYRice Derica WEVP-Global Services, CFOS - Sale+OE$77.14-11,162413,250-3%-$861,085+1+1+9
2017-02-02
LLYZakrowski Donald AChief Accounting OfficerS - Sale$77.52-2,0004,129-33%-$155,04000+9
2017-02-01
LLYLilly Endowment Inc10%S - Sale$77.35-220,000125,355,8040%-$17,016,8400+1+9
2016-12-16
LLYLilly Endowment Inc10%S - Sale$72.59-200,000125,575,8040%-$14,518,4770+1+5
2016-12-16
LLYZakrowski Donald AChief Accounting OfficerS - Sale$72.13-1,0003,531-22%-$72,1300+1+5
2016-12-16
LLYTai Jackson PDirP - Purchase$72.64+1,37548,815+3%+$99,8800+1+5
2016-12-16
LLYMahony SusanSVP, Pres, Lilly OncologyS - Sale$72.65-20,24281,903-20%-$1,470,6160+1+5
2016-12-16
LLYHoover R DavidDirP - Purchase$71.85+50035,004+1%+$35,9250+1+5
2016-12-16
LLYBarnes Melissa SChief Eth, Cmpl Ofcr, SVP, ERMS - Sale$82.23-2,0939,023-19%-$172,1070+1+5
M
2016-10-04
LLYCrowe Maria APres, Mfg. OperationsS - Sale$81.37-2,24892,484-2%-$182,9270-2-12+6
AM
2016-08-11
LLYTai Jackson PDirP - Purchase$80.43+5,77345,323+15%+$464,3480-1-2+2
2016-08-12
LLYTai Jackson PDirP - Purchase$80.42+2,56042,110+6%+$205,875-1-1-20
2016-07-29
LLYLilly Endowment Inc10%S - Sale$82.94-205,000125,775,8040%-$17,001,8800-2-5-9
2016-07-28
LLYLilly Endowment Inc10%S - Sale$82.87-240,000125,980,8040%-$19,888,5680-1-5-8
2016-07-28
LLYZakrowski Donald AChief Accounting OfficerS - Sale$83.16-1,2134,790-20%-$100,8730-1-5-8
2016-07-12
LLYLilly Endowment Inc10%S - Sale$79.54-210,000126,220,8040%-$16,703,82000+1-3
2016-07-07
LLYLilly Endowment Inc10%S - Sale$79.14-225,000126,430,8040%-$17,806,3580+2+3-3
2016-06-30
LLYLilly Endowment Inc10%S - Sale$78.46-215,000126,655,8040%-$16,869,9420+1+6-5
2016-06-29
LLYLilly Endowment Inc10%S - Sale$77.86-220,000126,870,8040%-$17,129,163+1+1+6-5

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top